News

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

Jennifer Sonsiadek, Nurse Manager of Saint Luke’s Clinical Forensic Program, talks to KCTV about how Saint Luke’s has been leading the way and innovating clinical forensic care provided in Kansas City and the nation for 50 years.

The care a person receives immediately following abuse or assault has a significant effect on their physical, emotional, and psychological well-being.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Over the years, they have done everything together: graduated high school, tied the knot, bought their first home, and raised a family. For all they have shared, they never dreamed of sharing a cancer diagnosis.